| P50 | author | Yao-Tseng Chen | Q108791762 |
| | Rhonda K Yantiss | Q114342030 |
| P2093 | author name string | Erika Hissong | |
| | Elizabeth P Crowe | |
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| | Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. | Q24539206 |
| | Era of universal testing of microsatellite instability in colorectal cancer | Q24596823 |
| | Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 |
| | Association between single nucleotide polymorphisms in the hMSH3 gene and sporadic colon cancer with microsatellite instability | Q28143782 |
| | Colorectal cancer due to deficiency in DNA mismatch repair function: a review | Q28262308 |
| | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 |
| | Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 |
| | Microsatellite instability in cancer of the proximal colon | Q29620692 |
| | Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer | Q30588580 |
| | MSIsensor: microsatellite instability detection using paired tumor-normal sequence data | Q30724354 |
| | Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data | Q33631924 |
| | Application of molecular diagnostics for the detection of Lynch syndrome | Q34088809 |
| | Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma | Q82602354 |
| | Immunostaining for mismatch repair (MMR) protein expression in colorectal cancer is better and easier to interpret when performed on diagnostic biopsies | Q83283869 |
| | Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer | Q84284659 |
| | Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel | Q84452748 |
| | Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma | Q84570529 |
| | How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation? | Q87645153 |
| | NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer | Q87930810 |
| | Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study | Q34102606 |
| | Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). | Q34557362 |
| | Microsatellite instability in colorectal cancer-the stable evidence | Q34616565 |
| | BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing | Q35446668 |
| | Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing | Q35740291 |
| | Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers | Q35790190 |
| | Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results | Q35925275 |
| | Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer | Q35988113 |
| | MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations | Q35996745 |
| | Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice | Q36494281 |
| | Extensive molecular screening for hereditary non-polyposis colorectal cancer | Q36641429 |
| | Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 |
| | Feasibility of screening for Lynch syndrome among patients with colorectal cancer | Q37103121 |
| | Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels | Q37130135 |
| | Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline | Q37968220 |
| | Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. | Q37988465 |
| | Mismatch repair deficiency testing in clinical practice | Q38741029 |
| | A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome | Q38773988 |
| | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry | Q39514722 |
| | Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. | Q40468182 |
| | Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair | Q42134566 |
| | Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. | Q42607034 |
| | Identifying Lynch syndrome | Q42607152 |
| | The InSiGHT database: utilizing 100 years of insights into Lynch syndrome. | Q43907143 |
| | Interobserver variability in the evaluation of mismatch repair protein immunostaining. | Q44193701 |
| | Colon cancer mutation: prognosis/prediction--response | Q45770597 |
| | Microsatellite instability detection by next generation sequencing | Q45790131 |
| | Microsatellite instability and colorectal cancer prognosis. | Q46831092 |
| | The FDA Oncology Center of Excellence and precision medicine. | Q48361599 |
| | Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas | Q50106907 |
| | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. | Q50876217 |
| | Should the grading of colorectal adenocarcinoma include microsatellite instability status? | Q51118570 |
| | Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. | Q51442155 |
| | Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. | Q51772302 |
| | Molecular Biomarkers for the Evaluation of Colorectal Cancer. | Q52794464 |
| | Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma | Q56582933 |
| | The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer | Q58635831 |
| | Hereditary colorectal cancer | Q73088287 |
| | Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors | Q77639637 |
| | Histopathology and Mismatch Repair Status of 458 Consecutive Colorectal Carcinomas | Q79203530 |
| P433 | issue | 11 | |
| P921 | main subject | DNA mismatch repair | Q2984243 |
| | colorectal cancer | Q188874 |
| | microsatellite | Q265193 |
| P304 | page(s) | 1756-1766 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing | |
| P478 | volume | 31 | |